17. Multiple system atrophy Clinical trials / Disease details


Clinical trials : 118 Drugs : 163 - (DrugBank : 49) / Drug target genes : 61 - Drug target pathways : 112

  
5 trials found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT04782830
(ClinicalTrials.gov)
February 5, 20211/3/2021Use of Accelerometer for Quantification of Neurogenic Orthostatic Hypotension SymptomsUse of Accelerometer for Quantification of Neurogenic Orthostatic Hypotension SymptomsOrthostatic; Hypotension, Neurogenic;Autonomic Failure;Pure Autonomic Failure;Multiple System Atrophy; Hypotension, ParkinsonismDevice: Accelerometer;Drug: placebo pill;Drug: Midodrine or atomoxetine pillVanderbilt University Medical CenterNULLRecruiting40 Years80 YearsAll29N/AUnited States
2NCT04620382
(ClinicalTrials.gov)
November 9, 202027/10/2020Effect of Midodrine vs Abdominal Compression on Cardiovascular Risk Markers in Autonomic Failure PatientsEffect of Midodrine vs Abdominal Compression on Cardiovascular Risk Markers in Autonomic Failure PatientsNeurogenic Orthostatic Hypotension;Autonomic Failure;Pure Autonomic Failure;Multiple System Atrophy;Parkinson DiseaseDrug: Midodrine;Drug: Placebo pill;Device: Abdominal compression;Device: sham compressionVanderbilt University Medical CenterNational Heart, Lung, and Blood Institute (NHLBI)Recruiting40 Years80 YearsAll31Early Phase 1United States
3NCT03482297
(ClinicalTrials.gov)
March 1, 201822/3/2018Automated Abdominal Binder for Orthostatic HypotensionRandomized, Double-blind, Sham-controlled to Evaluate the Effects of an Automated Abdominal Binder in Improving Orthostatic Tolerance in Autonomic Failure Patients With Disabling Orthostatic HypotensionOrthostatic Hypotension;Autonomic Failure;Pure Autonomic Failure;Multiple System AtrophyDevice: automated abdominal binder;Device: Sham binder;Drug: Placebo;Drug: MidodrineVanderbilt University Medical CenterNational Heart, Lung, and Blood Institute (NHLBI)Recruiting40 Years80 YearsAll31Phase 1/Phase 2United States
4NCT02897063
(ClinicalTrials.gov)
September 20167/9/2016Effects of Midodrine and Droxidopa on Splanchnic Capacitance in Autonomic FailureThe Effects of Midodrine and Droxidopa on Splanchnic Capacitance in Autonomic Failure Aim 2 of RDCRN (Rare Diseases Clinical Research Network) Project 2Autonomic Failure;Pure Autonomic Failure;Multiple System Atrophy;Parkinson Disease;Orthostatic HypotensionDrug: Droxidopa;Drug: Midodrine;Drug: PlaceboVanderbilt University Medical CenterNULLRecruiting40 Years80 YearsAll34Phase 1United States
5NCT02429557
(ClinicalTrials.gov)
April 201521/4/2015Hemodynamic Mechanisms of Abdominal Compression in the Treatment of Orthostatic Hypotension in Autonomic FailureHemodynamic Mechanisms of Abdominal Compression in the Treatment of Orthostatic Hypotension in Autonomic FailureOrthostatic Hypotension;Pure Autonomic Failure;Multiple System Atrophy;Autonomic FailureOther: Abdominal compression;Other: Sham abdominal compression;Drug: Placebo pill;Drug: midodrineVanderbilt University Medical CenterNational Heart, Lung, and Blood Institute (NHLBI)Recruiting18 Years80 YearsAll29Phase 1United States